Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

ClinicalTrials.gov ID: NCT00000918

Public ClinicalTrials.gov record NCT00000918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 9:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Open-Label Comparative Trial of Salvage Antiretroviral Therapies for HIV-Infected Individuals With Virological Evidence of Nelfinavir Treatment Failure as Reflected by Plasma HIV RNA Concentration of >= 1,000 Copies/ml

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and effectiveness of combining several anti-HIV drugs in order to decrease plasma viral load (level of HIV in the blood) in HIV-positive patients who have failed nelfinavir (NFV) treatment. In order to determine the ability of a drug regimen to decrease viral load after drug treatment has failed, it is best to test a variety different of drug "cocktails" (drug regimens). The drug cocktails in this study include 2 new nucleoside reverse transcriptase inhibitors (NRTIs), efavirenz (an NNRTI, non-nucleoside reverse transcriptase inhibitor), and either 1 or 2 protease inhibitors. It is important to include multiple drugs from different groups in a drug cocktail since combinations containing fewer drugs are likely to fail.

Study identification

NCT ID
NCT00000918
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jan 31, 2002
Last update posted
May 20, 2012

Ends 2002

United States locations

U.S. sites
38
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Univ of Alabama at Birmingham Birmingham Alabama 35294
Univ of Southern California / LA County USC Med Ctr Los Angeles California 900331079
UCLA CARE Ctr Los Angeles California 90095
Willow Clinic Menlo Park California 94025
San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco California 941102859
San Francisco Gen Hosp San Francisco California 941102859
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium San Jose California 951282699
Marin County Specialty Clinic San Rafael California 94903
San Mateo AIDS Program / Stanford Univ Stanford California 943055107
Stanford Univ Med Ctr Stanford California 943055107
Univ of Colorado Health Sciences Ctr Denver Colorado 80262
Howard Univ Washington D.C. District of Columbia 20059
Univ of Miami School of Medicine Miami Florida 331361013
Emory Univ Atlanta Georgia 30308
Northwestern Univ Med School Chicago Illinois 60611
Cook County Hosp Chicago Illinois 60612
Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois 60612
Indiana Univ Hosp Indianapolis Indiana 462025250
Division of Inf Diseases/ Indiana Univ Hosp Indianapolis Indiana 46202
Methodist Hosp of Indiana / Life Care Clinic Indianapolis Indiana 46202
Harvard (Massachusetts Gen Hosp) Boston Massachusetts 02114
Beth Israel Deaconess - West Campus Boston Massachusetts 02215
St Louis Regional Hosp / St Louis Regional Med Ctr St Louis Missouri 63112
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215
Beth Israel Med Ctr New York New York 10003
Bellevue Hosp / New York Univ Med Ctr New York New York 10016
Chelsea Ctr New York New York 10021
Cornell Univ Med Ctr New York New York 10021
Mount Sinai Med Ctr New York New York 10029
Univ of Rochester Medical Center Rochester New York 14642
Univ of North Carolina Chapel Hill North Carolina 275997215
Duke Univ Med Ctr Durham North Carolina 27710
Univ of Cincinnati Cincinnati Ohio 452670405
Case Western Reserve Univ Cleveland Ohio 44106
Ohio State Univ Hosp Clinic Columbus Ohio 432101228
Univ of Pennsylvania at Philadelphia Philadelphia Pennsylvania 19104
Julio Arroyo West Columbia South Carolina 29169
Univ of Washington Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2012 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000918 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →